Early Dose Optimisation of Golimumab in Nonresponders to Induction Treatment for Ulcerative Colitis Is Effective and Supported by Pharmacokinetic Data

George Philip, Freddy Cornillie, J. Omoniyi Adedokun, Richard Melsheimer, Paul Rutgeerts, Jean Frédéric Colombel, Colleen Marano

Research output: Contribution to journalArticlepeer-review

8 Scopus citations

Fingerprint

Dive into the research topics of 'Early Dose Optimisation of Golimumab in Nonresponders to Induction Treatment for Ulcerative Colitis Is Effective and Supported by Pharmacokinetic Data'. Together they form a unique fingerprint.

Medicine & Life Sciences